Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Godman

Showing results (451-460 of 479) with videos related to

Pageof 48
Sort By:
Jac-Antimicrobial Resistance|March 26, 2025
Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countriesZikria Saleem, Catrin E Moore, Aubrey C Kalungia, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Plos One|December 29, 2017
Policies for biosimilar uptake in Europe: An overviewEvelien Moorkens, Arnold G Vulto, Isabelle Huys, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Frontiers in Pharmacology|April 9, 2020
Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the FutureBrian Godman, Debashis Basu, Yogan Pillay, et al.
Hospital Practice (1995)|March 21, 2020
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the futureBrian Godman, Debashis Basu, Yogan Pillay, et al.
Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Expert Review of Anti-Infective Therapy|September 23, 2023
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistanceTiyani Milta Sono, Eugene Yeika, Aislinn Cook, et al.
Current Medical Research and Opinion|June 24, 2021
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the futureBrian Godman, Mainul Haque, Santosh Kumar, et al.
Life (Basel, Switzerland)|July 2, 2021
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing CountriesBrian Godman, Abiodun Egwuenu, Mainul Haque, et al.
Pageof 48

Showing results (451-460 of 479) with videos related to

Sort By:
Pageof 48
Jac-Antimicrobial Resistance|March 26, 2025
Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countriesZikria Saleem, Catrin E Moore, Aubrey C Kalungia, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Plos One|December 29, 2017
Policies for biosimilar uptake in Europe: An overviewEvelien Moorkens, Arnold G Vulto, Isabelle Huys, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Frontiers in Pharmacology|April 9, 2020
Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the FutureBrian Godman, Debashis Basu, Yogan Pillay, et al.
Hospital Practice (1995)|March 21, 2020
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the futureBrian Godman, Debashis Basu, Yogan Pillay, et al.
Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Expert Review of Anti-Infective Therapy|September 23, 2023
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistanceTiyani Milta Sono, Eugene Yeika, Aislinn Cook, et al.
Current Medical Research and Opinion|June 24, 2021
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the futureBrian Godman, Mainul Haque, Santosh Kumar, et al.
Life (Basel, Switzerland)|July 2, 2021
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing CountriesBrian Godman, Abiodun Egwuenu, Mainul Haque, et al.
Pageof 48